DA Davidson lowered the firm’s price target on Clorox (CLX) to $169 from $171 and keeps a Neutral rating on the shares. The company reported a Q2 earnings beat, with some charcoal shipments shifted to Q2 from Q3, while the promotional levels have returned to pre-COVID levels, the analyst tells investors in a research note. Top-line performance was skewed by unusually hard comparison however given the post-cyberattack channel replenishment a year ago, the firm added.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX: